|
Merck & Co (NYSE: MRK)
Links:
Quote,
Opinion,
Profile,
Chart
New Adobe Media Player - Sponsored Link
Ad - www.Adobe.com May 14 2008 10:19PM GMT
Moreover Technologies - Merck & Co news
Merck & Co news - more than 340 categories of real-time RSS news feeds
[$$] Vioxx Verdict Against Merck Is Overturned (at The Wall Street Journal Online)
Can Cancer Cure Pfizer? (at Forbes.com)
No Big Ripple for Merck Vioxx Verdict (at TheStreet.com)
Appeals court overturns $7.75 mln Vioxx verdict (Reuters)
An appeals court in Texas overturned a $7.75 million verdict against Merck & Co involving its withdrawn pain drug Vioxx on Wednesday, ruling that evidence presented at trial failed to prove the medicine caused the heart attack suffered by the plaintiff's husband.
Merck says appeals court overturns verdict in Vioxx case (AP)
A Texas appeals court on Wednesday overturned a multimillion-dollar verdict against Merck & Co. in one of the few trials it lost over its withdrawn painkiller Vioxx.
Court Overturns Merck Vioxx Verdict (at TheStreet.com)
Wednesday's Winners & Losers: Virgin Mobile (at TheStreet.com)
Closing Glance: Pharmaceuticals climb (AP)
Shares of large pharmaceutical companies closed higher Wednesday as the broader market gained ground on a better-than-expected consumer price report from the Labor Department, easing inflation concerns.
A Market Crash Is Coming (at Motley Fool)
Health Winners & Losers: Merck (at TheStreet.com)
Merck says Texas appeals court overturns Vioxx jury verdict (at MarketWatch)
InPlay: Merck confirms it wins appeal in VIOXX case (Briefing.com)
Merck Wins Appeal in VIOXX(R) Case (Business Wire)
WHITEHOUSE STATION, N.J.----Merck & Co., Inc. said today a Texas appellate court overturned the April 2006 verdict of a state court jury in Starr County, Texas, in the VIOXX product liability case Garza v.
Vioxx $32 mln jury verdict against Merck reversed: report (at MarketWatch)
Reversal in $32 Million Vioxx Case Is Icing on Merck's Cake (at The Wall Street Journal Online)
Vioxx Verdict Against Merck Reversed (at SmartMoney.com)
The Research Trap (at Forbes.com)
Awash in Counterfeit Drugs, India May Pay More for Foreign Approval (at The Wall Street Journal Online)
Biotech Stocks: Schering-Plough leads drug stocks higher (at MarketWatch)
Drug stocks rise early Wednesday, led by Schering-Plough Corp., which got a boost after analysts at Bernstein upped their price target on the stock to $25 from $22.
Opening Glance: Pharmaceuticals (AP)
Shares of large pharmaceutical companies opened higher Wednesday as the broader market gained ground following the Labor Department's report that consumer prices only rose 0.2 percent in April, down from March's inflation rate.
Yahoo! Finance: MRK News
Latest Financial News for MERCK CO INC
Shareholders Say Yes To Novartis
The pharma company invests in a lesser-known biopharma company.
A Shot Of Big Pharma
Hardly any news out of big drug companies has been good lately, but it could be just the time to buy.
The Stall-Out In Mega-Caps
No more Valium at the bedside, so now where do we make money?
Teva's Conquers Via Generics
The drug maker meets expectations, but gets hurt on acquisition costs.
Sponsor's Content: Earth in the Balance Sheet: Sustainability Reports
Sure, the pictures are nice. But in-depth sustainability reports are more than good PR. They provide better information to stakeholders and rich data to guide wiser management decisions.
Teva Expands Its Generic Hold
The drug maker meets expectations, but gets hurt on acquisition costs.
Sniffles And Sneezes
Over at In The Pipeline, chemist Derek Lowe takes a look at the failed effort to get a combo pill of Merck's allergy pill Singulair and Schering-Plough's allergy pill Claritin. The Food and Drug Administration recently said the combination was...
The Luckiest Guy In The Drug Business
Pfizer announces what may be the weirdest deal in biotech. And, really, it makes sense.
U.S. Stocks Slip Ahead Of Expected Rate Cut
Wall Street edged lower Tuesday, but the loss was modest after more woeful data on the housing market.
Street Slips As Fed Deliberates
Investors anxiously look ahead to the central bank's interest rate decision.
U.S. Market Limps Along On Cautious Trading
Mixed economic data preyed on risk-averse investors as the Fed meets in D.C.
Schering Shears Costs To Offset Vytorin
The pharmaceutical company beats estimates aided by a recent acquisition and cost-cutting.
Schering Glitters, But Is It Gold?
Chief Executive Fred Hassan puts on a brilliant conference call. But is his company a value or a value trap?
Belt-Tightening Boosts Schering
The pharmaceutical company beats estimates aided by a recent acquisition and cost-cutting.
Merck And Schering's Uneasy Alliance
Merck reported earnings; Schering-Plough comes next. Will the two partners tell the same story?
Forbes Beltway Index: Earnings Revisions
Equity analysts have recently cut or raised their profit forecasts for these Forbes Beltway Index members.
Stable Outlook For Merck
Despite flat first-quarter sales and its black eye over Vytorin, the pharma giant maintains its guidance for year.
Stocks Down After Bank Of America Profit Report
This is a transcript of the Market Update: Open video report.
Wall Street Runs Out Of Gas
Friday's gains were a distant memory as weak earnings and fresh highs for oil took the wind out of investors' sails.
BofA Bad, Merck Good, Stocks Sink
Wall Street got off to a slower open as profits dropped at the bank and soared at the drugmaker.
A Host Of Earnings Reports Ahead
This is a transcript of the Market Update: Week Ahead video report.
BofA, Merck To Set Next Week's Tone
With a laundry list of earnings and little economic data, the rally will live or die based on corporate reports.
The Long Wait For Pfizer
Some good news, some bad news and not enough reasons to be excited.
Oil Soars, Stocks Struggle Higher
Wall Street worked its way to a modest gain Tuesday in a seesaw session.
Vytorin's Man In The Middle
Cardiologist James Stein raises new questions about the handling of a key Vytorin study.
The Vytorin Letters
A congressional investigation turns up more dirt on the controversial testing of the cholesterol drug.
Forbes.com: mrk
The latest Forbes.com news on the ticker mrk.
Appeals court overturns $7.75 mln Vioxx verdict
NEW YORK (Reuters) - An appeals court in Texas overturned a $7.75 million verdict against Merck & Co involving its withdrawn pain drug Vioxx on Wednesday, ruling that evidence presented at trial failed to prove the medicine caused the heart attack suffered by the plaintiff's husband.
Merck says appeals court overturns verdict in Vio
TRENTON, N.J. (AP) - A Texas appeals court on Wednesday overturned a multimillion-dollar verdict against Merck & Co. in one of the few trials it lost over its withdrawn painkiller Vioxx.
Court Overturns Merck Vioxx Verdict
A Texas appeals court reverses a verdict related to a 2006 case of a heart attack victim.
Closing Glance: Pharmaceuticals climb
NEW YORK (AP) - Shares of large pharmaceutical companies closed higher Wednesday as the broader market gained ground on a better-than-expected consumer price report from the Labor Department, easing inflation concerns.
Merck Wins Appeal in VIOXX(R) Case
Merck & Co., Inc. said today a Texas appellate court overturned the April 2006 verdict of a state court jury in Starr County, Texas, in the VIOXX product liability case Garza v. Merck. The Texas
Opening Glance: Pharmaceuticals
NEW YORK (AP) - Shares of large pharmaceutical companies opened higher Wednesday as the broader market gained ground following the Labor Department's report that consumer prices only rose 0.2 percent in April, down from March's inflation rate.
Seven Summits Research Releases Alerts on AIG, HA
CHICAGO, May 14 /PRNewswire/ -- Seven Summits Research issues PriceWatch Alerts for key stocks. Seven Summits Strategic Investments' PriceWatch Alerts are available at http://www.iotogo
MSN Money News - MRK
News about Merck & Co Ord Shs
Merck Wins Appeal in VIOXX® Case
Merck to Reduce U.S. Sales Force by 1,200 Positions
Merck Extends Enrollment Deadline in Program to Resolve U.S. VIOXX® Product Liability Lawsuits
Merck.com - Corporate News
Merck.com - Corporate News
Merck Reports First-Quarter 2008 Financial Results
Merck to Hold First-Quarter 2008 Sales and Earnings Conference Call and Webcast on April 21
Merck Announces Second-Quarter 2008 Dividend
Merck.com - Financial News
Merck.com - Financial News
International Council of Nurses/ Merck Mobile Library Project: The Healing Power of Information
Many African nations lack a critical tool in the fight against AIDS, malaria and other diseases: nurses.
“In our country, we should have more than 22,000 nurses, but there are only 9,000 now,” says Banda Aaron, a teacher at the Lewanika School of Nursing in Mongu, Zambia. This shortage is particularly problematic because nurses are the primary health care providers for the vast majority of Zambians.
New Jersey Performing Arts Center: The Art of Good Education
Actor and musician Terrance Kennedy can do something most teachers would never dare: Get a teenage boy to do a plie in front of his friends.
“Once you create an environment of mutual respect and trust, they don’t mind the plie," Mr. Kennedy says, referring to the graceful ballet movement that’s often part of the theater and dance classes he teaches at New Jersey schools.
Building and Ethical South Africa One Step at a Time
Willem Landman , Ph.D., grew up during apartheid in South Africa, an experience that ignited a passion for justice and helped him become a powerful force for social change in his country.
Today, Dr. Landman uses that same directness to build consensus and foster positive change form the inside out as chief executive officer of the Ethics Institute of South Africa (EthicSA), a non-profit organization that promotes and advances ethical practices in health care, business and government
Medical Students Fight a Silent Killer among Asian and Pacific Islanders
Steven Lin discovered his calling when his brother-in-law was diagnosed with hepatitis B at just 22. “He was healthy one day and doubled over in pain the next,” Mr. Lin, now himself 22, recalls. “At the hospital, he was told that he would likely have liver cancer by age 40. That shook my world.”
Merck Company Foundation Expands Network of Immunization Training Centers in Africa
The Merck Company Foundation announced today a $2.8 million commitment to establish two new immunization training centers in Uganda and Zambia and to expand the Foundation's support of two existing centers in Kenya and Mali as part of the Merck Vaccine Network – Africa
Merck.com - Feature Stories About Merck
Merck.com - Feature Stories About Merck
Two Merck Medicines Recommended for Approval in the European Union
Merck/Schering-Plough Pharmaceuticals Comments on Results of the ENHANCE Study
Statement on IMPROVE-IT Study
Merck.com - Product News
Merck.com - Product News
Merck & Co., Inc. (NYSE: MRK)
Merck & Co., Inc. (NYSE: MRK) is one of the largest pharmaceutical companies in the world. The
headquarters of the company is located in Whitehouse Station, NJ. It was established in 1891 as the
United States subsidiary of the German company now known as Merck KGaA. In common with many other
German assets in the United States, Merck & Co. was confiscated in 1917 during World War I and set up
as an independent company. It is currently one of the top 7 largest pharmaceutical companies in the
world both by capital and revenue.
Merck & Co. describes itself as a "a global research-driven pharmaceutical company." Merck discovers,
develops, manufactures and markets a broad range of innovative products to improve human and animal
health, directly and through its joint ventures.
| 